Table 1.
Demographics and clinical characteristics of our cohort
| Control (n=79) |
FGR (n=35) |
P-value | |
|---|---|---|---|
| Gestational Age at MRI (weeks) | 30.1 (18 – 40) | 30.8 (22 – 37) | 0.12 |
| Maternal Age (years) | 26 (18–42) | 22 (18 – 41) | 0.06 |
| Male Gender, n (%) | 32 (41%) | 14 (40%) | 0.95 |
| Race or Ethnicity, n (%) | 0.11 | ||
| Black | 45 (57%) | 29 (83%) | |
| White | 18 (23%) | 3 (9%) | |
| Hispanic | 9 (11%) | 2 (6%) | |
| Other or Unknown | 7 (9%) | 1 (2%) | |
| Asymmetric Growth, n (%) | n/a | 25 (71%) | |
| Abnormal Doppler US, n (%) | n/a | 16 (46%) | |
| Gestational Age at Birth (weeks)f | 39 (37–41) | 37 (28 – 41) | < 0.01 |
| Birth Weight (grams)€ | 3443 (2634 – 4483) | 2284 (335 – 3688) | < 0.01 |
| Maternal Hypertensive Disorders, n (%)§ | N/A | 7 (20%) |
Data presented as median (range), unless otherwise noted;
N/A = not applicable;
f
GA at birth available for 72 controls and 34 FGR;
€
Birth weight data available for 65 controlsand 34 FGR; 15 patients were lost to follow-up;
§
Includes chronic hypertension, preeclampsia and HELP syndrome